Quick Answer
RAPID MICRO BIOSYSTEMS, INC. reported Cash and Equivalents of $20.03 million for fiscal year 2025.
RAPID MICRO BIOSYSTEMS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $20.03M | +18.4% |
| 2024 | $16.91M | -30.4% |
| 2023 | $24.29M | -10.3% |
| 2022 | $27.06M | -84.8% |
| 2021 | $178.39M | +493.1% |
| 2020 | $30.08M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $18.95M | -14.1% | +3.3% |
| June 30, 2025 | $18.33M | -50.6% | -3.0% |
| March 31, 2025 | $18.91M | -15.7% | +11.8% |
| December 31, 2024 | $16.91M | -30.4% | -23.3% |
| September 30, 2024 | $22.04M | -7.3% | -40.6% |
| June 30, 2024 | $37.12M | +29.4% | +65.5% |
| March 31, 2024 | $22.43M | -8.1% | -7.6% |
| December 31, 2023 | $24.29M | -10.3% | +2.1% |
- RAPID MICRO BIOSYSTEMS, INC. showed an increase of +18.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, RAPID MICRO BIOSYSTEMS, INC.’s cash and equivalents has declined by 33.4% (from $30.08 million to $20.03 million).
- The most recent figure is from RAPID MICRO BIOSYSTEMS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: